Εμφανίζονται 1 - 20 Αποτελέσματα από 69 για την αναζήτηση '"скорость оседания эритроцитов"', χρόνος αναζήτησης: 0,82δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Πηγή: Лабораторная диагностика. Восточная Европа. :324-335

  3. 3
  4. 4
    Academic Journal

    Συνεισφορές: Исследование выполнено при финансовой поддержке гранта РФФИ Аспиранты №19-315-90061 «Взаимосвязь нарушений феррокинетики и метаболических изменений при сахарном диабете».

    Πηγή: Medical Immunology (Russia); Том 26, № 1 (2024); 57-66 ; Медицинская иммунология; Том 26, № 1 (2024); 57-66 ; 2313-741X ; 1563-0625

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.mimmun.ru/mimmun/article/view/2623/1715; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10399; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10400; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10401; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10402; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10403; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10404; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10405; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10406; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10709; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/10710; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2623/12667; Климонтов В.В., Тян Н.В., Фазуллина О.Н., Мякина Н.Е., Лыков А.П., Коненков В.И. Клинические и метаболические факторы, ассоциированные с хроническим воспалением низкой интенсивности, у больных сахарным диабетом 2 типа // Сахарный диабет, 2016. Т. 19, № 4. С. 295-302.; Прохоренко Т.С., Зима А.П., Саприна Т.В., Мусина Н.H., Шахманова Н.С., Васильева О.А., Новицкий В.В. Значение определения маркеров воспаления у беременных с анемическим синдромом и ожирением // Медицинская иммунология, 2018. Т. 20, № 5. С. 639-646. doi:10.15789/1563-0625-2018-5-639-646.; Саприна Т.В., Мусина Н.Н., Прохоренко Т.С., Зима А.П. Способ дифференциальной диагностики анемического синдрома при сахарном диабете 1 и 2 типа // Патент РФ на изобретение № 2770744 C1 Российская Федерация / 21.04.2022. МПК G01N 33/49.; Сахин В.Т., Григорьев М.А., Крюков Е.В., Казаков С.П., Рукавицын О.А. Влияние гепцидина и растворимого рецептора трансферрина на развитие анемии хронических заболеваний у ревматических пациентов // Гематология. Трансфузиология. Восточная Европа, 2020. Т. 6, № 3. С. 311-318.; Суржикова Г.С., Клочкова-Абельянц С.А. Гепсидин-25: новые возможности в диагностике железодефицитных анемий и анемий хронических заболеваний // Клиническая лабораторная диагностика, 2017. Т. 62, № 7. С. 414-417.; Addo L., Ikuta K., Tanaka H., Toki Y., Hatayama M., Yamamoto M., Ito S., Shindo M., Sasaki Y., Shimonaka Y., Fujiya M., Kohgo Y. The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS). Int. J. Hematol., 2016, Vol. 103, no. 1, pp. 34-43.; de Domenico I., Zhang T.Y., Koening C.L., Branch R.W., London N., Lo E., Daynes R.A., Kushner J.P., Li D., Ward D.M., Kaplan J. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest., 2010, Vol. 120, no. 7, pp. 2395-2405.; Esser N., Legrand-Poels S., Piette J., Scheen A.J., Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract., 2014, Vol. 105, no. 2, pp. 141-150.; Ganz T., Nemeth E. Hepcidin and iron homeostasis. Biochim. Biophys. Acta, 2012, no. 1823, pp. 1434-1443.; Huang J., Karnchanasorn R., Ou H.Y., Feng W., Chuang L.M., Chiu K.C., Samoa R. Association of insulin resistance with serum ferritin and aminotransferases-iron hypothesis. World J. Exp. Med., 2015, Vol. 5, no. 4, pp. 232-243.; Huth C., Beuerle S., Zierer A., Heier M., Herder C., Kaiser T., Koenig W., Kronenberg F., Oexle K., Rathmann W., Roden M., Schwab S., Seissler J., Stöckl D., Meisinger C., Peters A., Thorand B. Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2diabetes: the KORA F4 study. Eur. J. Endocrinol., 2015, Vol. 173, no. 5, pp. 643-653.; Kulaksiz H., Fein E., Redecker P., Stremmel W., Adler G., Cetin Y. Pancreatic beta-cells express hepcidin, an iron-uptake regulatory peptide. J. Endocrinol., 2008, Vol. 197, no. 2, pp. 241-249.; Nemeth E., Ganz T. The Role of hepcidin in iron metabolism. Acta Haematol., 2009. no. 122. pp. 78-86.; Pasricha S.R., Drakesmith H. Iron deficiency anemia: problems in diagnosis and prevention at the population level. Hematol. Oncol. Clin. North. Am., 2016, Vol. 30, no. 2, pp. 309-325.; Pechlaner R., Weiss G., Bansal S., Mayr M., Santer P., Pallhuber B., Notdurfter M., Bonora E., Willeit J., Kiechl S. Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitus. Diabetes Metab. Res. Rev., 2016, Vol. 32, no. 2, pp. 187-192.; Rabinovitch A., Suarez-Pinzon W.L. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem. Biophys., 2007, Vol. 48, no. 2-3, pp. 159-163.; Uno S., Imagawa A., Okita K., Sayama K., Moriwaki M., Iwahashi H., Yamagata K., Tamura S., Matsuzawa Y., Hanafusa T., Miyagawa J., Shimomura I. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia, 2007, Vol. 50, no. 3, pp. 596-601.; Wang Z., Shen X.-H., Feng W.-M., Ye G.-F., Qiu W., Li B. Analysis of inflammatory mediators in prediabetes and newly diagnosed type 2 diabetes patients. J. Diabetes Res., 2016, Vol. 2016, no. 4, pp. 1-10.; Yamamoto Y., Yamamoto H. RAGE-Mediated inflammation, type 2 diabetes, and diabetic vascular complication. Front. Endocrinol. (Lausanne), 2013, Vol. 4, no. 4, pp. 1-10.; https://www.mimmun.ru/mimmun/article/view/2623

  5. 5
    Academic Journal

    Συγγραφείς: Strilchuk, L. M.

    Πηγή: Ukrainian Therapeutical Journal; № 2 (2019); 96-102
    Украинский терапевтический журнал; № 2 (2019); 96-102
    Український терапевтичний журнал; № 2 (2019); 96-102

    Περιγραφή αρχείου: application/pdf

    Σύνδεσμος πρόσβασης: http://utj.com.ua/article/view/177170

  6. 6
  7. 7
  8. 8
  9. 9
    Academic Journal

    Πηγή: Modern Rheumatology Journal; Том 14, № 4 (2020); 65-69 ; Современная ревматология; Том 14, № 4 (2020); 65-69 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2020-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://mrj.ima-press.net/mrj/article/view/1070/1029; Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008 Oct;22(5): 773-92. doi:10.1016/j.berh.2008.08.006.; Chen DY, Lan JL, Lin FJ, Hsieh TY. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still’s disease. Arthritis Rheum. 2005 Jun 15;53(3):320-7. doi:10.1002/art.21164.; Najam F, Fuchs HA. Cardiac tamponade: a life-threatening complication of Still’s disease. J Clin Rheumatol. 2001 Apr;7(2):97-101. doi:10.1097/00124743-200104000-00009.; Biron C, Chambellan A, Agard C, et al. Acute respiratory failure revealing adult-onset Still’s disease: diagnostic value of low glycosylated ferritin level. Clin Clin Rheumatol. 2006 Sep;25(5):766-8. doi:10.1007/s10067-005-0078-0. Epub 2005 Nov 10.; Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008 May;75(3):291-4. doi:10.1016/j.jbspin.2007.06.016. Epub 2008 Apr 9.; Mercan R, Bitik B, Tufan A, et al. The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal. 2016 Sep;30(5):597-601. doi:10.1002/jcla.21908. Epub 2015 Dec 14.; Uslu AU, Kü cü k A, Sahin A, et al. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis. 2015 Sep;18(7):731-5. doi:10.1111/1756-185X.12582. Epub 2015 Apr 21.; Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012 Dec;225(2):456-60. doi:10.1016/j.atherosclerosis.2012.09.009. Epub 2012 Sep 21.; Suppiah A, Malde D, Arab T, et al. The prognostic value of the neutrophil-lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg. 2013 Apr;17(4):675-81. doi:10.1007/s11605-012-2121-1. Epub 2013 Feb 1.; Yin Y, Wang J, Wang X, et al. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis. Clinics (Sao Paulo). 2015 Jul;70(7):524-30. doi:10.6061/clinics/2015(07)10. Epub 2015 Jul 1.; Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophilto-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014 May 29;106(6):dju124. doi:10.1093/jnci/dju124. Print 2014 Jun.; Torun S, Tunc BD, Suvak B, et al. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol. 2012 Oct;36(5):491-7. doi:10.1016/j.clinre.2012.06.004. Epub 2012 Jul 27.; Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992 Mar; 19(3):424-30.; Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991 Mar;70(2):118-36.; Ruscitti P, Cipriani P, Masedu F, et al. Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMC Med. 2016 Dec 1;14(1): 194. doi:10.1186/s12916-016-0738-8.; Gu L, Ma X, Li H, et al. Prognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram. Sci Rep. 2016 Mar 31;6:23846. doi:10.1038/srep23846.; Mc Ardle A, Flatley B, Pennington SR, et al. Early biomarkers of joint damage in rheumatoid and psoriatic arthritis. Arthritis Res Ther. 2015 Jun 1;17(1):141. doi:10.1186/s13075-015-0652-z.; Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012 Jan 26;5(1):2. doi:10.1186/1755-7682-5-2.; Liu X, Shen Y, Wang H, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study. Mediators Inflamm. 2016;2016:8191254. doi:10.1155/2016/8191254. Epub 2016 Mar 24.; Bozbay M, Uyarel H. Neutrophil-to-lymphocyte ratio: a novel and simple prognostic marker for infective endocarditis. J Crit Care. 2015 Aug;30(4):822. doi:10.1016/j.jcrc.2015.04.115. Epub 2015 May 1.; Yilmaz H, Cakmak M, Inan O, et al. Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis? Ren Fail. 2015 Mar;37(2):225-9. doi:10.3109/0886022X.2014.982477. Epub 2014 Nov 14.; Seo JY, Suh CH, Jung JY et al. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis. Medicine (Baltimore). 2017 Jul;96(29):e7546. doi:10.1097/MD.0000000000007546.

  10. 10
  11. 11
  12. 12
    Academic Journal

    Περιγραφή αρχείου: application/pdf

    Relation: УДК 616.72–002.77.–085; https://repository.pdmu.edu.ua/handle/123456789/10801

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
    Academic Journal

    Περιγραφή αρχείου: application/pdf

    Relation: УДК 616.72–002.77–071; https://repository.pdmu.edu.ua/handle/123456789/3003